Happel David 4
4 · Sagimet Biosciences Inc. · Filed Mar 28, 2024
Insider Transaction Report
Form 4
Happel David
DirectorPresident & CEO
Transactions
- Purchase
Series A Common Stock
2024-03-26$5.27/sh+12,100$63,731→ 639,200 total
Footnotes (1)
- [F1]Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.24 per share to $5.2999 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each price.